MHC-I-driven antitumor immunity counterbalances low absorbed doses of radiopharmaceutical therapy
The study shows that assessing MHC-I expression in tumors could help predict treatment outcomes and guide personalized therapy strategies. Go to this publication at the JRC Publications Repository
Brochure: EC-CvC at a Glance, European Commission Initiative on Cervical Cancer
The brochure outlines the EU Initiative on Cervical Cancer (CvC), which aims to update evidence-based guidelines and develop a quality assurance scheme for cervical cancer care services...
The Cancer Performance Tracker published on the European Cancer Inequalities Registry (ECIR)
This new functionality provides a snapshot of EU countries' performance across the different cancer domains, compared to the EU level as well as over time. Cancer Performance Tracker